China approves its first homegrown coronavirus vaccine, developed by Sinopharm.

China’s Sinopharm says its Covid-19 vaccine is 79% effective.

Chinese regulators have approved the country’s first homegrown coronavirus vaccine, developed by state-owned pharmaceutical giant Sinopharm, officials announced Thursday.

That’s on top of the 1.5 million doses administered on “high-risk groups” by the end of November, Zeng added.

Among those inoculated, fewer than 0.1% developed a light fever, and about two people per million developed “relative serious adverse reactions” such as allergies, according to Zeng.

READ ALSO:  CNN Stands By Its Reports On Lekki Massacre

Beijing Biological Products Institute Co., a Sinopharm subsidiary, said in a statement published Wednesday that interim results show the Sinopharm vaccine is safe and people who received two doses produced high-level antibodies.

But the statement gave no details on the data, such as the trial size, the number of infections in the trial and side effects.
Coronavirus vaccines developed by Sinopharm have already been administered to hundreds of thousands of people under a controversial emergency use program approved by the Chinese government.

READ ALSO:  FG Plan Evacuating Nigerians From Ukraine

By November, nearly 1 million people had received a Sinopharm vaccine, according to the company’s chairman, though he didn’t specify which of the company’s two vaccines they had received.

Do you have any information or event for candid reporters to publish or cover? Kindly Call us on 09019260726 or send us message on Whatsapp number 07034623382 or send us an email contact@candidreporters.com

Disclaimer: Candid Reporters publishes news, information, sports, opinions, and Interviews. The site includes both reported and edited content. Unmoderated posts and Comments expressed here do not reflect the opinions of Candid Reporters or any employee thereof..

LEAVE A REPLY

Please enter your comment!
Please enter your name here